PinnedHow to value an early-stage listed Biotech company with no revenues?Disclaimer: The objective of this write up ( a part of my MBA case study)is for the reader to understand how financial valuation is done…Jun 25, 2023Jun 25, 2023
How Pooled Pension Capital could transform drug development finance by bridging the valley of death…Disclaimer and Personal NoteNov 17, 2024Nov 17, 2024
Investment Memo 3 — ADC Innovation: Spotlight on Myricx Bio’s Novel ApproachDisclaimer: This memo is for research purposes and reflects my interest in writing an investment blog. It should not be considered a…Nov 12, 2024Nov 12, 2024
GPay’s Evolution in India’s Digital Finance RevolutionIn the rapidly evolving landscape of digital finance, Google Pay (GPay) stands at a pivotal crossroads. Originally conceived as a digital…Sep 13, 2024Sep 13, 2024
Investment Memo Biotech : Case 2Company Overview: Scenic Biotech is a pioneering biopharmaceutical company leveraging its proprietary Cell-Seq platform to discover and…Jul 22, 2024Jul 22, 2024
Exploring Innovative Business Models in Biotech: The Case of Royalty PharmaThe biopharmaceutical industry is marked by high risks, significant R&D costs, and the potential for substantial returns. Among the various…Jun 13, 2024Jun 13, 2024
Mastering Your Startup’s Cap Table: A Step-by-Step Practical Guide to build Cap Table from Seed to…You’ve probably read tons of articles about the different rounds of VC funding and all the associated terms, but how often do you come…May 29, 2024May 29, 2024
Investment Memo — Biotech: Case 1Disclaimer: An investment memo on Laverock Therapeutics, leverage their own GEiGS platform. This memo is for research purposes and…May 27, 2024May 27, 2024
“Strategic Acquisitions in Pharma: How Industry Trends and Competitor Actions Shape the Future to…Recently, the pharmaceutical industry has witnessed a series of notable acquisitions, particularly in specific areas such as…May 20, 2024May 20, 2024
Opportunities in Rare Diseases: The Economics of Orphan DrugsIn the realm of pharmaceuticals, the pursuit of treatments for rare diseases stands as both a noble endeavour and a complex business…Feb 29, 2024Feb 29, 2024
Navigating Venture Debt: A Strategic Guide for Start-upsIn my recent blog post, I delved into the founder’s perspective on various aspects of venture funding, covering topics such as funding…Dec 9, 2023Dec 9, 2023
Navigating the Landscape of Venture Capital: A Founder’s Take on Funding ProvisionsVenture capital, often hailed as the lifeblood of start-ups, can be a double-edged sword for founders. While it brings the promise of…Nov 12, 2023Nov 12, 2023
“Navigating the Parkinson’s Disease Landscape: Breakthroughs, Innovations, Areas and companies to…Parkinson’s disease (PD), a formidable neurodegenerative adversary, unleashes a cascade of motor dysfunction, disrupting lives with…Oct 29, 2023Oct 29, 2023
Charting the Course Against Alzheimer’s: Current Challenges, Promising strategies and opportunities…Following a series of networking events, I recently attended, meeting with a diverse cohort of investors and founders, I found myself…Sep 24, 2023Sep 24, 2023
“Navigating the Valuation Maze: Unravelling the Complexities of Biotech Start-Up Valuation” —…Generally, the valuation of a start-up is difficult because of the negative earnings, lack of accurate financial information, probability…Sep 10, 2023Sep 10, 2023
“Empowering Health Innovation: The Journey of Queo Health Towards a Transformed Healthcare…In India, the lack of accessible and traceable health information has led to fragmented care and uninformed decisions. This issue is deeply…Aug 12, 2023Aug 12, 2023
Monoclonal antibodies as a weapon to fight against Covid-19 — Implications & opportunitiesNeutralizing monoclonal antibodieshas been used as an emergency therapeutic intervention to reduce viral load of patients with mild to…Feb 10, 2022Feb 10, 2022
The surveillance role of embryonic microglia during neurogenesisThe work by Rosin et al has advanced our understanding of how radial glial cells (RGC) during embryonic development are constantly under…Jan 19, 2022Jan 19, 2022
Market approval to product launch of drugs -What matters the mostGenerally we talk about the market approval of the drug by the FDA or EMA, have you ever wondered what it would take from market approval…Dec 21, 2021Dec 21, 2021
Emerging topics in Parkinson’s diseases (PD) — new avenues to explore in the therapeutic…Parkinson’s disease (PD) is a neurodegenerative disease that is characterised by motor dysfunctions. Some of the symptoms of the disease…Apr 13, 2021Apr 13, 2021
